These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 34369014)
1. Closing the gap between in vivo and in vitro omics: using QA/QC to strengthen ex vivo NMR metabolomics. Maroli AS; Powers R NMR Biomed; 2023 Apr; 36(4):e4594. PubMed ID: 34369014 [TBL] [Abstract][Full Text] [Related]
2. Designing a quality assurance process for quality control of nuclear magnetic resonance metabolomics studies of human blood. Muti IH; Gonzalez Sanchez-Dahl M; Zhong AB; Weng J; Füzesi MV; Kivisäkk P; Hyman BT; Arnold SE; Feldman AS; Mercaldo ND; Cheng LL NMR Biomed; 2023 Apr; 36(4):e4868. PubMed ID: 36330660 [TBL] [Abstract][Full Text] [Related]
4. The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective. Rankin NJ; Preiss D; Welsh P; Burgess KE; Nelson SM; Lawlor DA; Sattar N Atherosclerosis; 2014 Nov; 237(1):287-300. PubMed ID: 25299963 [TBL] [Abstract][Full Text] [Related]
7. NMR-based metabolomics and fluxomics: developments and future prospects. Giraudeau P Analyst; 2020 Apr; 145(7):2457-2472. PubMed ID: 32154527 [TBL] [Abstract][Full Text] [Related]
8. Quantitative NMR-Based Metabolomics on Tissue Biomarkers and Its Translation into In Vivo Magnetic Resonance Spectroscopy. Serkova NJ; Davis DM; Steiner J; Agarwal R Methods Mol Biol; 2019; 1978():369-387. PubMed ID: 31119675 [TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis in magnetic resonance spectroscopy: from metabolic profiling to in vivo biomarkers. Serkova NJ; Brown MS Bioanalysis; 2012 Feb; 4(3):321-41. PubMed ID: 22303835 [TBL] [Abstract][Full Text] [Related]
10. Potential of in vitro nuclear magnetic resonance of biofluids and tissues in clinical research. Dubey R; Sinha N; Jagannathan NR NMR Biomed; 2023 Apr; 36(4):e4686. PubMed ID: 34970810 [TBL] [Abstract][Full Text] [Related]
11. Sample Preparation and Data Analysis for NMR-Based Metabolomics. Mal TK; Tian Y; Patterson AD Methods Mol Biol; 2021; 2194():301-313. PubMed ID: 32926373 [TBL] [Abstract][Full Text] [Related]
12. Can NMR solve some significant challenges in metabolomics? Nagana Gowda GA; Raftery D J Magn Reson; 2015 Nov; 260():144-60. PubMed ID: 26476597 [TBL] [Abstract][Full Text] [Related]
14. Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics. Marshall DD; Powers R Prog Nucl Magn Reson Spectrosc; 2017 May; 100():1-16. PubMed ID: 28552170 [TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Metabolomics Using NMR. Sharma U; Jagannathan NR Methods Mol Biol; 2019; 2037():195-213. PubMed ID: 31463847 [TBL] [Abstract][Full Text] [Related]
16. Quantitative NMR-Based Biomedical Metabolomics: Current Status and Applications. Crook AA; Powers R Molecules; 2020 Nov; 25(21):. PubMed ID: 33158172 [TBL] [Abstract][Full Text] [Related]
17. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research. Emwas AH Methods Mol Biol; 2015; 1277():161-93. PubMed ID: 25677154 [TBL] [Abstract][Full Text] [Related]
18. Expanding the limits of human blood metabolite quantitation using NMR spectroscopy. Nagana Gowda GA; Gowda YN; Raftery D Anal Chem; 2015 Jan; 87(1):706-15. PubMed ID: 25485990 [TBL] [Abstract][Full Text] [Related]
19. Applications of NMR spectroscopy to systems biochemistry. Fan TW; Lane AN Prog Nucl Magn Reson Spectrosc; 2016 Feb; 92-93():18-53. PubMed ID: 26952191 [TBL] [Abstract][Full Text] [Related]